Epigenetics Market 2022 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market for epigenetics is estimated at USD 2,060.2 million in the year 2022, is projected to reach a size of USD 8,229.2 million by 2030, growing at a compound annual growth rate (CAGR) of 18.9% over the forecast period 2022-2030. The growth of the epigenetics market is driven by factors such as growing investments, funds, and grants for epigenetics research, reducing costs of genome sequencing, and rising application of epigenetic enzymes in drug discovery & development. Increasing applications of epigenetics in non-oncology is expected to provide lucrative opportunities for the global market throughout the forecast period.

Get a free sample report to learn more about study. Request Free Sample Report

REGIONAL ANALYSIS

In the terms of region, it is studied across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these regions, North America captures the major market share, and followed by Europe. The growth of the regional market is likely to be driven by favorable government initiatives and private players investment for the development and adoption of NGS technologies.

The Asia Pacific is anticipated to grow at the highest CAGR during the forecast period, attributed to improving healthcare infrastructure in the emerging economies in the region. Countries such as India, China, and Japan are among the key contributors to the growth of the market in the region.

Looking for a more specific analysis? Get the detailed report you need with a custom request. Request Custom Report

SEGMENTATION ANALYSIS

Based on product & service, the epigenetics market has been classified into kits & reagents, enzymes, instruments and accessories, software, and service. The kits & reagents segment accounted for the largest share in the epigenetics market in 2021. The kits & reagents segment is further classified into antibodies, chip-seq kits, bisulfite conversion kits, whole genome amplification kits, 5-hmc and 5-mc analysis kits, histones, and other kits & reagents.

By method, the market has been divided into DNA methylation, histone modifications, and other methods. During forecast period, histone modifications is anticipated to witness lucrative growth.

On the basis of technique, the epigenetics market has been classified into NGSs, PCR & qPCR, mass spectrometry, sonication, and other techniques. NGS technique dominated the epigenetics market in 2021.

On the basis of application, the epigenetics market has been classified into oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and other applications. Cardiovascular diseases application segment is expected to flourish with the highest CAGR from 2022 to 2030.

Based on end user, the epigenetics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinics. Academic & research institutes are the dominant segment in the epigenetics market.

Looking for help with your next report? Our team is here to help answer any questions you may have. Inquire before buying

COMPANIES COVERAGE

The global epigenetics market is consolidated at top, with top 10 leading players accounting for majority of the market share. Major companies in epigenetics market includes Abcam plc, Active Motif, Inc., Creative Biogene, Bio-Rad Laboratories, Diagenode, EpiCypher, EpiGentek Group Inc., Everon Life Sciences, F. Hoffmann-La Roche Ltd, Fios Genomics, GenomeScan, Illumina, Inc., Merck KGaA, New England Biolabs, PacBio, PerkinElmer, Promega Corporation, Qiagen, Thermo Fisher Scientific, and Zymo Research Corporation.